PathAI grabs $75 mln Series B
Boston-based PathAI, a provider of AI-powered research tools and services for pathology, has raised $75 million in Series B funding. The investors include Merck Global Health Innovation Fund and Bristol-Myers Squibb.
4 November 2019•1 min read
